INS and type 1 diabetes mellitus: Future research may also focus on designing therapeutic peptide prediction models specific to different types of diabetes, such as immunomodulatory peptides for type 1 diabetes (T1D) and insulin-sensitizing peptides for type 2 diabetes (T2D), thereby advancing precision medicine and enhancing clinical translational potential.